Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finalgon in acute low back pain
NCT01708915Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2012
- Primary completion
- Apr 2013
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nonivamide + nicoboxil in acute low back pain, sponsored by Boehringer Ingelheim. Started Oct 2012; status: completed.
02
Drugs
nonivamide + nicoboxil
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT01708915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01708915.